ES523419A0 - Un metodo para preparar derivados de 4-hidroxi-2-quinolona - Google Patents

Un metodo para preparar derivados de 4-hidroxi-2-quinolona

Info

Publication number
ES523419A0
ES523419A0 ES523419A ES523419A ES523419A0 ES 523419 A0 ES523419 A0 ES 523419A0 ES 523419 A ES523419 A ES 523419A ES 523419 A ES523419 A ES 523419A ES 523419 A0 ES523419 A0 ES 523419A0
Authority
ES
Spain
Prior art keywords
hydroxy
preparing
quinolone derivatives
quinolone
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES523419A
Other languages
English (en)
Spanish (es)
Other versions
ES8504130A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nippon Shinyaku Co Ltd
Original Assignee
Nippon Shinyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Shinyaku Co Ltd filed Critical Nippon Shinyaku Co Ltd
Publication of ES523419A0 publication Critical patent/ES523419A0/es
Publication of ES8504130A1 publication Critical patent/ES8504130A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/10—Expectorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
ES523419A 1982-06-21 1983-06-20 Un metodo para preparar derivados de 4-hidroxi-2-quinolona Expired ES8504130A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP57107366A JPS58225065A (ja) 1982-06-21 1982-06-21 ２−キノロン誘導体

Publications (2)

Publication Number Publication Date
ES523419A0 true ES523419A0 (es) 1985-04-01
ES8504130A1 ES8504130A1 (es) 1985-04-01

Family

ID=14457260

Family Applications (4)

Application Number Title Priority Date Filing Date
ES523419A Expired ES8504130A1 (es) 1982-06-21 1983-06-20 Un metodo para preparar derivados de 4-hidroxi-2-quinolona
ES530391A Granted ES530391A0 (es) 1982-06-21 1984-03-08 Un metodo para preparar derivados de 4-hidroxi-2-quinolona.
ES530392A Expired ES8504719A1 (es) 1982-06-21 1984-03-08 Un metodo para preparar derivados de 4-hidroxi-2-quinolona.
ES530393A Expired ES8504723A1 (es) 1982-06-21 1984-03-08 Un metodo para preparar derivados de 4-hidroxi-2-quinolonas.

Family Applications After (3)

Application Number Title Priority Date Filing Date
ES530391A Granted ES530391A0 (es) 1982-06-21 1984-03-08 Un metodo para preparar derivados de 4-hidroxi-2-quinolona.
ES530392A Expired ES8504719A1 (es) 1982-06-21 1984-03-08 Un metodo para preparar derivados de 4-hidroxi-2-quinolona.
ES530393A Expired ES8504723A1 (es) 1982-06-21 1984-03-08 Un metodo para preparar derivados de 4-hidroxi-2-quinolonas.

Country Status (7)

Country Link
US (1) US4526894A (de)
EP (1) EP0101330B1 (de)
JP (1) JPS58225065A (de)
KR (1) KR900004041B1 (de)
CA (1) CA1191140A (de)
DE (1) DE3377797D1 (de)
ES (4) ES8504130A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5916878A (ja) * 1982-07-20 1984-01-28 Mitsubishi Yuka Yakuhin Kk ２，４−ジヒドロキシ−３−アセチルキノリン類の製造方法
US5179107A (en) * 1990-09-07 1993-01-12 Schering Corporation Antiviral quinolinone compounds
US5378694A (en) * 1990-09-07 1995-01-03 Schering Corporation Acyl and alkoxy substituted quinolines
EP0549729B1 (de) * 1990-09-07 1997-12-17 Schering Corporation Antivirale und antihypertensive verbindungen
US5179093A (en) * 1991-05-10 1993-01-12 Schering Corporation Quinoline-diones
JP2943725B2 (ja) * 1996-01-17 1999-08-30 大日本インキ化学工業株式会社 キノリノン誘導体及びそれを有効成分とする抗アレルギー剤
KR100908418B1 (ko) * 2001-06-20 2009-07-21 액티버스 파마 컴퍼니 리미티드 퀴놀리논 유도체 의약 조성물 및 그의 제조 방법
GB0519969D0 (en) * 2005-09-30 2005-11-09 Argenta Discovery Ltd Quinoline compounds
EA015358B1 (ru) * 2005-09-30 2011-06-30 Пульмаджен Терапьютикс (Эсме) Лимитед Хинолины и их терапевтическое применение
US8173812B2 (en) * 2007-04-04 2012-05-08 Pulmagen Therapeutics (Asthma) Limited Quinolines and their therapeutic use
KR101846029B1 (ko) 2008-08-06 2018-04-06 메디베이션 테크놀로지즈 엘엘씨 폴리(ａｄｐ-리보오스)폴리머라아제 (ｐａｒｐ)의 디히드로피리도프탈라지논 억제제
CN102869258A (zh) 2010-02-03 2013-01-09 生物马林药物股份有限公司 用于pten基因缺失相关疾病的治疗的聚（adp-核糖）聚合酶（parp）的二氢吡啶并酞嗪酮抑制剂
EP2533640B1 (de) 2010-02-08 2016-09-28 Medivation Technologies, Inc. Verfahren zur synthese von dihydropyridophthalazinonderivaten
CN103282365B (zh) 2010-10-21 2017-12-29 麦迪韦逊科技有限公司 结晶的(8S,9R)‑5‑氟‑8‑(4‑氟苯基)‑9‑(1‑甲基‑1H‑1,2,4‑三唑‑5‑基)‑8,9‑二氢‑2H‑吡啶并[4,3,2‑de]酞嗪‑3(7H)‑酮甲苯磺酸盐
CN102146068A (zh) * 2011-01-20 2011-08-10 南开大学 3-苯甲酰基-4-羟基香豆素衍生物及其类似物与在除草方面的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1770480B2 (de) * 1968-05-22 1977-09-29 Basf Ag, 6700 Ludwigshafen Verfahren zur herstellung von 2,4- dihydroxychinolin
CH606285A5 (de) * 1974-12-17 1978-10-31 Ciba Geigy Ag
US4086349A (en) * 1975-07-30 1978-04-25 Mitsubishi Yuka Pharmaceutical Co., Ltd. Quinolopyran-4-one-2-carboxylic acid derivatives and salts thereof as novel compounds and as medicines for treatment of allergic asthma
DE2806879A1 (de) * 1978-02-17 1979-08-23 Sandoz Ag 4-hydroxy-2-chinolinon-3-carbonsaeure- esterderivate
EP0062001B1 (de) * 1981-03-24 1987-05-27 Ciba-Geigy Ag Acyl-chinolinonderivate, Verfahren zu ihrer Herstellung, diese enthaltende pharmazeutische Präparate und ihre Verwendung

Also Published As

Publication number Publication date
ES530392A0 (es) 1985-05-01
ES530393A0 (es) 1985-05-01
EP0101330A3 (en) 1984-08-22
ES8504718A1 (es) 1985-05-01
US4526894A (en) 1985-07-02
DE3377797D1 (en) 1988-09-29
JPS58225065A (ja) 1983-12-27
ES8504719A1 (es) 1985-05-01
CA1191140A (en) 1985-07-30
KR840005101A (ko) 1984-11-03
ES8504723A1 (es) 1985-05-01
ES8504130A1 (es) 1985-04-01
KR900004041B1 (ko) 1990-06-09
ES530391A0 (es) 1985-05-01
EP0101330A2 (de) 1984-02-22
JPH0249306B2 (de) 1990-10-29
EP0101330B1 (de) 1988-08-24

Similar Documents

Publication Publication Date Title
ES505373A0 (es) Un metodo para preparar derivados de fenilpiperazina
ES554546A0 (es) Un procedimiento para preparar derivados de guanina
ES532536A0 (es) Un procedimiento para preparar un derivado de carbostirilo
ES530916A0 (es) Un procedimiento para preparar derivados de pirimidina
ES530024A0 (es) Un procedimiento para preparar derivados de pirazinona
ES537104A0 (es) Un procedimiento para preparar derivados de tiazina
ES528304A0 (es) Un procedimiento para preparar derivados de pirimidona
ES523419A0 (es) Un metodo para preparar derivados de 4-hidroxi-2-quinolona
ES534297A0 (es) Un procedimiento para preparar derivados de cefem
ES551064A0 (es) Un metodo para preparar derivados de cefem
ES535568A0 (es) Un procedimiento para preparar derivados de piridazinona
ES530020A0 (es) Un metodo para preparar derivados de 3-metilflavona
ES535381A0 (es) Un metodo para preparar un derivado de azuleno
ES550467A0 (es) Un metodo para preparar derivados de 9-bencilpurina
ES521361A0 (es) Un metodo para preparar un derivado 14-acilico de lankacidina.
ES525007A0 (es) Un procedimiento para producir derivados de tiazol
ES529034A0 (es) Un metodo para preparar nuevos compuestos de benzoilurea
ES535826A0 (es) Un metodo para preparar un derivado de 3-indolcarboxamida
ES534355A0 (es) Un metodo para preparar derivados de fenotiazina
ES521389A0 (es) Un metodo para preparar derivados de tiazolidina.
ES526177A0 (es) Un procedimiento para preparar derivados de pirimidona
ES529478A0 (es) Un procedimiento para preparar derivados de mitomicina
ES530855A0 (es) Un procedimiento para preparar derivados de benzotiazina
ES527738A0 (es) Un procedimiento para preparar derivados de piridona
ES527789A0 (es) Un procedimiento para preparar derivados de cicloalquenilo

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970401